FWPAY
Price:
$300
Market Cap:
$7.45M
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.[Read more]
Industry
Biotechnology
IPO Date
2014-10-15
Stock Exchange
PNK
Ticker
FWPAY
According to Forward Pharma A/S’s latest financial reports and current stock price. The company's current PE Ratio is -10.56. This represents a change of -Infinity% compared to the average of 0 of the last 4 quarters.
The mean historical PE Ratio of Forward Pharma A/S over the last ten years is -49.88. The current -10.56 PE Ratio has changed 2.02% with respect to the historical average. Over the past ten years (40 quarters), FWPAY's PE Ratio was at its highest in in the March 2013 quarter at 895.95. The PE Ratio was at its lowest in in the December 2014 quarter at -716.87.
Average
-49.88
Median
-33.66
Minimum
-161.02
Maximum
1.00
Discovering the peaks and valleys of Forward Pharma A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 265.33%
Maximum Annual PE Ratio = 1.00
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -161.02
Year | PE Ratio | Change |
---|---|---|
2021 | -25.71 | 194.80% |
2020 | -8.72 | -28.36% |
2019 | -12.17 | 146.47% |
2018 | -4.94 | -594.57% |
2017 | 1.00 | -100.70% |
2016 | -141.91 | -11.87% |
2015 | -161.02 | 265.33% |
2014 | -44.08 | -26.04% |
2013 | -59.59 | 43.21% |
2012 | -41.61 | -Infinity% |
The current PE Ratio of Forward Pharma A/S (FWPAY) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-15.53
5-year avg
-10.11
10-year avg
-49.88
Forward Pharma A/S’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forward Pharma A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Forward Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Forward Pharma A/S's PE Ratio?
How is the PE Ratio calculated for Forward Pharma A/S (FWPAY)?
What is the highest PE Ratio for Forward Pharma A/S (FWPAY)?
What is the 3-year average PE Ratio for Forward Pharma A/S (FWPAY)?
What is the 5-year average PE Ratio for Forward Pharma A/S (FWPAY)?
How does the current PE Ratio for Forward Pharma A/S (FWPAY) compare to its historical average?